These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 1815451

  • 1. Growth response in prepubertal children with idiopathic growth hormone deficiency during the first two years of treatment with human growth hormone. Analysis of the Kabi Pharmacia International Growth Study.
    Ranke MB, Guilbaud O.
    Acta Paediatr Scand Suppl; 1991; 379():109-15; discussion 116. PubMed ID: 1815451
    [Abstract] [Full Text] [Related]

  • 2. Derivation and validation of a mathematical model for predicting the response to exogenous recombinant human growth hormone (GH) in prepubertal children with idiopathic GH deficiency. KIGS International Board. Kabi Pharmacia International Growth Study.
    Ranke MB, Lindberg A, Chatelain P, Wilton P, Cutfield W, Albertsson-Wikland K, Price DA.
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1174-83. PubMed ID: 10199749
    [Abstract] [Full Text] [Related]

  • 3. Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short stature.
    Ranke MB, Lindberg A, Price DA, Darendeliler F, Albertsson-Wikland K, Wilton P, Reiter EO, KIGS International Board.
    Horm Res; 2007 Apr; 68(2):53-62. PubMed ID: 17228181
    [Abstract] [Full Text] [Related]

  • 4. Presence of magnetic resonance imaging abnormalities of the hypothalamic-pituitary axis is a significant determinant of the first 3 years growth response to human growth hormone treatment in prepubertal children with nonacquired growth hormone deficiency.
    Zenaty D, Garel C, Limoni C, Czernichow P, Léger J.
    Clin Endocrinol (Oxf); 2003 May; 58(5):647-52. PubMed ID: 12699449
    [Abstract] [Full Text] [Related]

  • 5. Growth hormone treatment and adverse events in Prader-Willi syndrome: data from KIGS (the Pfizer International Growth Database).
    Craig ME, Cowell CT, Larsson P, Zipf WB, Reiter EO, Albertsson Wikland K, Ranke MB, Price DA, KIGS International Board.
    Clin Endocrinol (Oxf); 2006 Aug; 65(2):178-85. PubMed ID: 16886957
    [Abstract] [Full Text] [Related]

  • 6. Growth in pre-pubertal children with myelomeningocele (MMC) on growth hormone (GH): the KIGS experience.
    Trollmann R, Bakker B, Lundberg M, Doerr HG.
    Pediatr Rehabil; 2006 Aug; 9(2):144-8. PubMed ID: 16449073
    [Abstract] [Full Text] [Related]

  • 7. Growth hormone treatment in prepubertal children with celiac disease and growth hormone deficiency.
    Giovenale D, Meazza C, Cardinale GM, Farinelli E, Mastrangelo C, Messini B, Citro G, Del Vecchio M, Di Maio S, Possenti I, Bozzola M.
    J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):433-7. PubMed ID: 18030209
    [Abstract] [Full Text] [Related]

  • 8. Insulin-like growth factor I and growth responses during the first year of growth hormone treatment in KIGS patients with idiopathic growth hormone deficiency, acquired growth hormone deficiency, turner syndrome and born small for gestational age.
    Cutfield WS, Lundgren F.
    Horm Res; 2009 Jan; 71 Suppl 1():39-45. PubMed ID: 19153504
    [Abstract] [Full Text] [Related]

  • 9. Who is treated with growth hormone today? The Executive Scientific Committee of the Kabi International Growth Study.
    Vanderschueren-Lodeweyckx M.
    Acta Paediatr Scand Suppl; 1990 Jan; 370():107-13; discussion 114. PubMed ID: 2260448
    [Abstract] [Full Text] [Related]

  • 10. The response to treatment with pituitary growth hormone: the New Zealand experience.
    Livesey JH, Cuneo RC, Donald RA, Harris RG, Ibberston HK, Costello JM, Holdaway IM, Gluckman PD, Fraser TR, Chapman GE.
    N Z Med J; 1989 Aug 09; 102(873):399-402. PubMed ID: 2761875
    [Abstract] [Full Text] [Related]

  • 11. Prader-Labhart-Willi syndrome: auxological response to a conventional dose of growth hormone in patients with classical growth hormone deficiency.
    Schmidt H, Bechtold S, Schwarz HP.
    Eur J Med Res; 2000 Jul 19; 5(7):307-10. PubMed ID: 10903191
    [Abstract] [Full Text] [Related]

  • 12. Bone age progression during the first year of growth hormone therapy in pre-pubertal children with idiopathic growth hormone deficiency, Turner syndrome or idiopathic short stature, and in short children born small for gestational age: analysis of data from KIGS (Pfizer International Growth Database).
    Darendeliler F, Ranke MB, Bakker B, Lindberg A, Cowell CT, Albertsson-Wikland K, Reiter EO, Price DA.
    Horm Res; 2005 Jul 19; 63(1):40-7. PubMed ID: 15627781
    [Abstract] [Full Text] [Related]

  • 13. Diagnosis and growth hormone (GH) therapy in children with GH deficiency: experience in King Chulalongkorn Memorial Hospital, Thailand.
    Wacharasindhu S, Supornsilchai V, Aroonparkmongkol S, Srivuthana S.
    J Med Assoc Thai; 2007 Oct 19; 90(10):2047-52. PubMed ID: 18041422
    [Abstract] [Full Text] [Related]

  • 14. [Treatment of hypophyseal dwarfism with biosynthetic growth hormone].
    Blümel P, Stögmann W.
    Wien Klin Wochenschr; 1989 Dec 22; 101(24):861-3. PubMed ID: 2623878
    [Abstract] [Full Text] [Related]

  • 15. Increased response, but lower responsiveness, to growth hormone (GH) in very young children (aged 0-3 years) with idiopathic GH Deficiency: analysis of data from KIGS.
    Ranke MB, Lindberg A, Albertsson-Wikland K, Wilton P, Price DA, Reiter EO.
    J Clin Endocrinol Metab; 2005 Apr 22; 90(4):1966-71. PubMed ID: 15634724
    [Abstract] [Full Text] [Related]

  • 16. Changes of thyroid function during long-term hGH therapy in GHD children. A possible relationship with catch-up growth?
    Seminara S, Stagi S, Candura L, Scrivano M, Lenzi L, Nanni L, Pagliai F, Chiarelli F.
    Horm Metab Res; 2005 Dec 22; 37(12):751-6. PubMed ID: 16372229
    [Abstract] [Full Text] [Related]

  • 17. Predictors of growth response to rhGH in short children before and after renal transplantation. German Study Group for Growth Hormone Treatment in Chronic Renal Failure.
    Wühl E, Haffner D, Tönshoff B, Mehls O.
    Kidney Int Suppl; 1993 Oct 22; 43():S76-82. PubMed ID: 8246375
    [Abstract] [Full Text] [Related]

  • 18. Catch-up growth in autosomal dominant isolated growth hormone deficiency (IGHD type II).
    Binder G, Iliev DI, Mullis PE, Ranke MB.
    Growth Horm IGF Res; 2007 Jun 22; 17(3):242-8. PubMed ID: 17360215
    [Abstract] [Full Text] [Related]

  • 19. Growth pattern and skeletal maturation following growth hormone therapy in growth hormone deficiency: factors influencing outcome.
    Bajpai A, Kabra M, Gupta AK, Menon PS.
    Indian Pediatr; 2006 Jul 22; 43(7):593-9. PubMed ID: 16891678
    [Abstract] [Full Text] [Related]

  • 20. Growth response in prepubertal children with idiopathic growth hormone deficiency during the first year of treatment with human growth hormone. Analysis of the Kabi International Growth Study.
    Ranke MB, Guilbaud O.
    Acta Paediatr Scand Suppl; 1990 Jul 22; 370():122-30. PubMed ID: 2260450
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.